Stocks to sell

The verdict is still out on the viability of Gores Guggenheim (NASDAQ:GGPI) stock. Source: Jeppe Gustafsson / Shutterstock.com Gores is a special purpose acquisition company (SPAC) with plans to merge with Polestar, an EV maker gaining serious attention. If you’re connected to the electric vehicle industry, the new normal presents both opportunities and frustrations. On

Peloton (NASDAQ:PTON) is making headlines again. This time it’s not a 21% single-day gain for PTON stock based on acquisition rumors. That was Monday. There are currently three big developments on the Peloton front. The company’s CEO is stepping down, while Peloton is also laying off a large chunk of its workforce and abandoning its

Digital World Acquisition Group (NASDAQ:DWAC) is likely to fall shortly after the SPAC (special purpose acquisition corp) merger with Trump Media & Technology Group (TMTG) closes. DWAC stock is at an exorbitantly high valuation, especially considering its potential earnings and dilution issues. Source: rafapress / Shutterstock This is way too high for a company that

In my most recent articles on Matterport (NASDAQ:MTTR), I’ve taken a bearish view on the stock. But I haven’t been bearish on MTTR stock primarily because of the firm’s prospects. Source: Matterport Instead, my view has been that the richly-priced shares  have more room to fall because the market has been shunning pricey growth stock on

QuantumScape (NYSE:QS) has big plans to become a major player in the electric battery industry as it claims it is “building the best battery.” QS stock benefitted greatly as electric vehicle (EV) manufacturers exploded in popularity during the pandemic. But as lofty valuations return to earth, real questions about QuantumScape’s business have become a sore

In one sense, stock-trading app Robinhood Markets (NASDAQ:HOOD) could hardly have timed its initial public offering better. HOOD stock went public on July 29 at $38 a share. Less than a week later, it hit an intraday high of $85 for a 124% gain. Source: OpturaDesign / Shutterstock.com Remember that this was a time of

Ocugen, Inc. (NASDAQ:OCGN) is a clinical-stage biopharmaceutical company struggling to find a direction and a bottom in 2022 as the pandemic persists. Investors looking to buy OCGN stock have several tough questions to ask and need straightforward answers to evaluate its shares. Source: shutterstock.com/PhotobyTawat I have written three articles on OCGN stock. I covered two

Oil and gas play Camber Energy (NYSEAMERICAN:CEI) has languished in the penny stock territory for a while now. After its price topped $4.85 per share last September, CEI stock has shed over 85% of its value. It is now back where it belongs, trading in the penny stock territory after the Reddit-fueled enthusiasm. Though penny

AMC Entertainment (NYSE:AMC) has seen its picture go a little fuzzy lately. AMC stock was one of 2021’s unexpected winners as it rode an unprecedented wave of social media interest. However, the name has now declined 75% from its 52-week highs and is down by about 40% just over the past six weeks alone. Source:

Even after a 60%-plus drop in shares of digital payments company Block (NYSE:SQ) — formerly known as Square — SQ stock is still trading at very high valuations. And the company faces a number of challenges that make it an unappealing investment. Source: Sergei Elagin / Shutterstock.com In addition to stiff competition from PayPal (NASDAQ:PYPL)

Clover Health (NASDAQ:CLOV) was supposed to be one of Chamath Palihapitiya’s biggest special purpose acquisition company (SPAC) wins. When Palihapitiya announced plans to take Clover public, traders gravitated to the play as a natural fit. The idea? CLOV stock would upend the sleepy health insurance industry with a big dose of Silicon Valley expertise. Source:

I recently wrote a bullish column on DoorDash (NYSE:DASH) stock, so I’m certainly not bearish on all delivery names. However, there are two very important differences between DASH stock and Grab Holdings (NASDAQ:GRAB) stock. Source: Hafiz Johari / Shutterstock.com Specifically, Grab operates in countries with much weaker economies and lower standards of living than DoorDash.

Amazon (NASDAQ:AMZN) is rising after yet another strong quarter. The overall news was good for the company, which managed to exceed expectations on several fronts. That sent shares of AMZN stock more than 10% higher.  Source: Eric Broder Van Dyke / Shutterstock.com At the same time, though, the report was far from perfect. In fact,

At first glance, California-headquartered life-sciences company Bionano Genomics (NASDAQ:BNGO) might seem like a good business to invest in. After all, BNGO stock is cheap and that is what traders should look for, right? Source: Dennis Diatel / Shutterstock.com The important lesson here is to avoid confusing “cheap” with “good.” As the old Benjamin Graham/Warren Buffett saying

Last month’s rate hike-driven drop for stocks drove another big slide for GameStop (NYSE:GME). But as the market eases slghtly about higher interest rates, GME stock — the one that started the whole meme-stock phenomenon — has started to bounce back. Source: Emil O / Shutterstock.com Briefly falling below $100 per share for the first

It’s been just over a year since traders on Reddit’s WallStreetBets incited the GameStop (NYSE:GME) trading frenzy and the term “meme stock” entered our lexicon. Early on, this retail army also set its sights on struggling movie theater chain AMC Entertainment (NYSE:AMC). An initial short squeeze in early 2021 took AMC stock from around $2

If you’re reading this, chances are, you’re not part of the 1% that handsomely benefitted from the prior housing and equities boom that capitalism created. Therefore, it’s difficult not to sympathize with the phenomenon known as meme stocks. There is a word in German that’s a favorite of mine to deploy from time to time:

Life sciences equipment manufacturer Bionano Genomics (NASDAQ:BNGO) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, it has failed to sustain investor interest, as its flagship optimal genome mapping tool Saphyr hasn’t gained much traction in the medical community. It continues to grow at

QuantumScape (NYSE:QS) is a speculative pre-revenue stage company operating in the next-generation electric battery industry. The company claims to have advanced technology that could represent a great leap forward in electric battery performance. However, short sellers published scathing criticisms of QuantumScape’s technology and management team last year, leading to a massive decline. QS stock is

I’ve written quite a few articles for InvestorPlace in which I’ve argued that a successful company doesn’t always equate to a promising stock. It’s crucial for investors to understand the power of market forces — and the influence of institutional investors. Case in point? Tilray (NASDAQ:TLRY). Fact of the matter is that TLRY stock is suffering